Sfoglia per AUTORE
RICOTTA R
Collezione AOU San Luigi di Orbassano

  

Items : 5

Avelumab as single agent for patients with metastatic or locally advanced urothelial cancer PD-L1+ unfit for cisplatin: The ARIES study in Journal of Clinical Oncology

2020
AOU San Luigi di Orbassano

Iacovelli R; Buti S; Buttigliero C; De Vivo R; Caserta C; Ferraú F; Galli L; Martelli V; Masini C; Mattioli R; Merler S; Milesi L; Naglieri E; Ricotta R; Rizzo M; Sacco C; Santini D; Tambaro R; Verri E; Santoni M;

Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2018 Aug;16(4):e945-e951. doi: 10.1016/j.clgc.2018.03.014. Epub 2018 Apr 19.

2018
ASL Cuneo 2
AOU San Luigi di Orbassano

Facchini G; Cartenì G; Sabbatini R; Del Bene G; Galli L; Caserta C; Multari AG; Bregni M; Massari F; Buti S; De Giorgi U; Zustovich F; Milella M; Calabrò F; Mancini ML; Tortora G; Vernieri C; Santini D; Sorarù M; Ricotta R; Masini C; Tucci M; Fedeli SL; Ortega C; Mecozzi A; Ratta R; Sternberg CN; Verzoni E; Fornarini G; et alii...

Prognostic value of neutrophil-to-lymphocyte ratio (NLR) in metastatic castrationresistant prostate cancer (mCRPC) pts receiving a new agent (NA)-based third line treatment: Final results from a multicenter Italian study in Journal of Clinical Oncology

2017
AOU San Luigi di Orbassano

Caffo O; Bria E; De Giorgi U; Tucci M; Biasco E; Fratino L; Facchini G; Iacovelli R; Re GL; Scagnoli S; Morelli F; D'Angelo A; Verderame F; Campadelli E; Ricotta R; Napolitano M; Sartori D; Borsellino N; Sperduti I; Maruzzo M;

Patients with metastatic castration-resistant prostate cancer (mCRPC) are primary resistant (PR) to the new agent (NA)-based second line: Clinical outcomes and prognostic factors of subsequent treatment with another NA in Journal of Clinical Oncology

2017
AOU San Luigi di Orbassano

Caffo O; Bria E; De Giorgi U; Tucci M; Biasco E; Fratino L; Rossetti S; Iacovelli R; Morelli F; D'Angelo A; Campadelli E; Verderame F; Borsellino N; Sartori D; Guida A; Ricotta R; Barni S; Maines F; Sperduti I; Zagonel V;

Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study. in European urology / Eur Urol. 2015 Jul;68(1):147-53. doi: 10.1016/j.eururo.2014.10.014. Epub 2014 Oct 25.

2015
AOU San Luigi di Orbassano

Caffo O; De Giorgi U; Fratino L; Alesini D; Zagonel V; Facchini G; Gasparro D; Ortega C; Tucci M; Verderame F; Campadelli E; Lo Re G; Procopio G; Sabbatini R; Donini M; Morelli F; Sartori D; Zucali P; Carrozza F; D'Angelo A; Vicario G; Massari F; Santini D; Sava T; Messina C; Fornarini G; La Torre L; Ricotta R; Aieta M; et alii...